Business
M1 Kliniken AG Reports Strong EBIT Growth of 11% and Achieves Earnings per Share of EUR 0.86
BERLIN - November 18, 2025 (NEWMEDIAWIRE) - M1 Kliniken AG (ISIN: DE000A0STSQ8) successfully closed the last nine months of 2025, continuing its profitable growth trajectory. Consistent implementation of efficiency measures and the targeted expan...
About this update from M1 Kliniken Ag
[{"type":"table","headerItems":[],"items":[{"val":[{"val":[{"type":"text","content":"BERLIN - November 18, 2025 (NEWMEDIAWIRE) - M1 Kliniken AG (ISIN: DE000A0STSQ8) successfully closed the last nine months of 2025, continuing its profitable growth trajectory. Consistent implementation of efficiency measures and the targeted expansion of medical capacities remain key priorities and have made a significant contribution to improved profits.","length":356,"tagName":"p"},{"type":"text","content":"Key Financials at a Glance","length":26,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Group revenue: +6.7% to EUR 274.3 million (YTD Q3 2024: EUR 257.2 million)","length":74,"tagName":"p"}]},{"val":[{"type":"text","content":"EBITDA: +9% to EUR 28.2 million (YTD Q3 2024: EUR 25.9 million)","length":63,"tagName":"p"}]},{"val":[{"type":"text","content":"EBIT: +11% to EUR 24.5 million (YTD Q3 2024: EUR 22.1 million)","length":62,"tagName":"p"}]},{"val":[{"type":"text","content":"EBIT margin: 8.9% (YTD Q3 2024: 8.6%)","length":37,"tagName":"p"}]},{"val":[{"type":"text","content":"EBT: +10% to EUR 24.4 million (YTD Q3 2024: EUR 22.2 million)","length":61,"tagName":"p"}]},{"val":[{"type":"text","content":"Earnings per share: EUR 0.86 (YTD Q3 2024: EUR 0.77)","length":52,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":349,"olType":false},{"type":"text","content":"Beauty-Segment: Profitability Significantly Increased Once Again","length":64,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue: +9.5% to EUR 77.8 million (YTD Q3 2024: EUR 71.0 million)","length":66,"tagName":"p"}]},{"val":[{"type":"text","content":"EBIT: +29.7% to EUR 21.1 million (YTD Q3 2024: EUR 16.3 million)","length":64,"tagName":"p"}]},{"val":[{"type":"text","content":"EBIT margin: 27.1% (YTD Q3 2024: 22.9%)","length":39,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":169,"olType":false},{"type":"text","content":"The Beauty segment remains the key growth driver of the Group. The positive development already seen in the first half of the year continued convincingly in the third quarter of 2025. In the first nine months of 2025, the segment continued to benefit from efficiency gains through optimized processes and higher utilization of medical capacities. A targeted pricing strategy aimed at attracting new customer groups supp...